QuiqMeds, Inc

Shifa Biomedical Corporation, based in Malvern, Pennsylvania, is a privately held biopharmaceutical company focused on the cost-effective development of drugs for cardiovascular disease. Established in 2006, the company specializes in the discovery of small molecule drugs, leveraging expertise in molecular biology, biochemistry, and medicinal chemistry. Shifa's most advanced compound targets dyslipidemia, aiming to significantly lower bad cholesterol (LDL-C) levels. By pursuing innovative approaches to regulate the PCSK9 protein, Shifa is developing a first-in-class oral small molecule therapy that could provide an effective alternative to existing injectable treatments. Generated from the website

Reaction Biology Corporation (RBC) is a premier provider of in vitro enzyme activity assays for HTS and profiling. Serving over 450 customers worldwide, we specialize in optimizing nanoliter scale assaying methods, allowing for high quality data with fast turnaround and economical pricing. RBC offers gold-standard radioisotope based assays in the Kinase, Methyltransferase, and HAT enzyme classes, as well as full suite of HDAC/SIRT assays. RBC also now provides an expanding line of active, human recombinant HMTs, including some exclusive complexes. Compound libraries, custom assay development, discovery partnerships and cell-based assays are also part of our portfolio of services.

PhaseBio Pharmaceuticals, located in Malvern, PA, is dedicated to developing innovative therapies for cardiovascular diseases, which currently affect one in four individuals. The company aims to address the pressing need for new treatment options by leveraging high-quality science and the expertise of its team to create a unique pipeline of medicines. Committed to improving patient outcomes and enhancing the healthcare system, PhaseBio focuses on overcoming the challenges associated with serious cardiovascular conditions. Their mission underscores a determination to deliver specialized therapies that can provide superior results for patients in need. Generated from the website